NCT00391339UnknownPhase 2
Bryophyllum p. Versus Nifedipine for the Treatment of Premature Contractions
Conditions
Drugs
Trial Snapshot
- Phase
- Phase 2
- Sponsor
- Weleda AG
- Enrollment
- 140
- Locations
- 1
Study Overview
Brief Summary
In a prospective, randomised study the efficacy and tolerability of bryophyllum p. (p.o) vs. nifedipine (p.o) will be proofed in a defined group of pregnant women with threatened preterm labour.
Study Design
- Study Type
- Interventional
- Allocation
- Randomized
- Intervention Model
- Parallel
- Primary Purpose
- Treatment
- Masking
- None
Eligibility Criteria
- Ages
- 18 Years to 45 Years (Adult)
- Sex
- Female
- Accepts Healthy Volunteers
- Yes
Inclusion Criteria
- Not provided
Exclusion Criteria
- •Bishop Score > 5
Investigators
Study Sites (1)
Loading locations...
Similar Trials
Completed
Phase 4
The Impact of Bryophyllum on Preterm DeliveryPreterm DeliveryPreterm ContractionsCervical ShorteningNCT00163579University Hospital, Basel, Switzerland26
Not yet recruiting
Phase 3
Effect of Parnfuti in prevention of stone formation and reduction of stone size in patients of renal stone disease.CTRI/2016/11/007425Department of Pharmacology100
Unknown
Not Applicable
A Clinical Study on the Treatment of Cerebral Small Vascular DiseaseCerebral Small Vessel DiseasesNCT04078204Peking Union Medical College Hospital300
Completed
Not Applicable
Ketamine gargle and nebulisation in post operative sore throatCTRI/2018/01/011165Dr Samrin Fiaz80
Active, not recruiting
Phase 1
A trial to compare the effects of nebivolol versus atenolol on various cardiovascular measurements including insulin sensitivity - Nebivolol trialHypertensionEUCTR2005-001214-40-GBImperial College London50